ANDA 211019, held by Cosette Pharms Nc. Lidocaine.
As of Nov 15, 2026, ANDA 211019 (Lidocaine), held by Cosette Pharms Nc, was first approved by FDA on Dec 12, 2018, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 12, 2018 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Lidocaine5% ยท ointment;topical | Lidocaine | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
